Clinical trials
Completed Phase 4 Inflammatory Bowel Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | 2 |
| James Lewis | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| University of Wisconsin, Madison | 2 |
| AbbVie | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Asan Medical Center | 1 |
| Astellas Pharma Europe Ltd. | 1 |
| Cedars-Sinai Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 40 |
| Colitis, Ulcerative | 18 |
| Crohn Disease | 17 |
| Intestinal Diseases | 3 |
| Digestive System Diseases | 2 |
| Fatigue | 2 |
| Gastrointestinal Diseases | 2 |
| Iron Deficiencies | 2 |
| Abdominal Pain | 1 |
| Anastomotic Leak | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.